Takeover is possible - I also would not welcome this.
Do you have any figures that support a positive CF quarter? By my reckoning, the only revenue will be derived from the end Nov shipment and we know lots about that now so revenue of 7.5M appears to be locked in. Costs will be around $9-10M and staff and OH's will be around 1.5M. My estimate is -$4.2M. Might be slightly less, if costs are towards the bottom end of that range but I cannot see how they can be CF positive. Maybe if they sell their shares in other companies they could be CF positive.
- Forums
- ASX - By Stock
- E25
- Ann: Revised Shipping Strategy Yields Substantial Cost Reduction
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

Ann: Revised Shipping Strategy Yields Substantial Cost Reduction, page-56
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
2 | 5119 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online